Symptom-Related Research from the Agency for Healthcare Research and Quality

Abstract

Recent reports on research supported by the Agency for Healthcare Research and Quality are summarized. These reports relate to use of aspirin for cardioprotection by patients taking NSAIDs, end of life care for nursing home residents with advanced directives, Cancer Patients' Satisfaction With Primary Care Pain Management, the need for increased medical training about adverse drug events, and dorsal root entry zone lesioning for central neuropathic pain. The research summarized in this report was abstracted from the AHRQ Research Activities.

Key Words:

• Agency for Healthcare Research and Quality
• AHRQ
• patient satisfaction
• cancer pain
• NSAIDs
• cardioprotection
• nursing homes
• end-of-life
• DREZ
• neuropathic

Additional information

Notes on contributors

Arthur G. Lipman

Cherokee Layson-Wolf, PharmD, is Assistant Professor at the University of Maryland School of Pharmacy. At the time that this review was conducted, she was a Community Care Pharmacy Practice Resident at Virginia Commonwealth University.

Perry G. Fine, MD, is Professor of Anesthesiology, School of Medicine and Associate Medical Director, Pain Management Center at the University of Utah Health Sciences Center, Salt Lake City; and National Medical Director, VistaCare, based in Scottsdale, AZ. This commentary is based on an article in Dr. Fine's VistaCare Palliative Medicine Monitor.

Jonathan R. Gavrin, MD, is the Internet editor for the Journal. He is Associate Professor of Anesthesiology and Adjunct Associate Professor of Medicine at the University of Washington School of Medicine; Associate Member, Fred Hutchinson Cancer Research Center; and Associate Director for Clinical Anesthesia Services, Harborview Medical Center.

Philip J. Wiffen, is the Regional Pharmaceutical and Prescribing Adviser, Anglia & Oxford Region of the National Health Service Executive, a member of the Oxford Regional Pain Relief Unit and Coordinating Editor of the Cochrane Collaboration Pain Palliative and Supportive Care Collaborative Review Group.

Philip J. Wiffen, BPharm, MRPharmS, MFPHM (Hon) is Regional Pharmaceutical and Prescribing Adviser, Anglia & Oxford Region of the National Health Service Executive, a member of the Pain Relief Unit, Churchill Hospital, and Coordinating Editor, Cochrane Collaboration Pain Palliative and Supportive Care Collaborative Review Group.

Howard A. Heit, practices pain medicine and addiction medicine in Fairfax, Virginia, and is Assistant Clinical Professor of Medicine at Georgetown University, Washington, DC. Dr. Heit was a member of the Liaison Committee on Pain and Addiction.